VIROMED MEDICAL AGVV

VIROMED MEDICAL AG

2.66EURD
+0.08+3.10%
At close at Mar 26, 16:36 GMT
EUR
No trades
See on Supercharts

VMED fundamentals

Key facts

Market capitalization‪33.21 M‬EUR
Basic EPS (TTM)−0.00EUR
Founded2021
CEOUwe Perbandt
About

Viromed Medical AG engages in the supply and sale of healthcare products for care clinics, general and rehabilitation hospitals, and retirement homes. It offers products relating to diagnostics, therapeutics, and cold plasma technology. The company is headquartered in Pinneberg, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪33.21 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
H1 '23
H2 '23
H1 '24

Growth and Profitability

Company’s recent performance and margins

Performance
H1 '23
H2 '23
H1 '24
‪‪−240.00 K‬‬
‪‪−160.00 K‬‬
‪‪−80.00 K‬‬
‪0.00‬
‪‪80.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−160.00 K‬‬
‪‪−120.00 K‬‬
‪‪−80.00 K‬‬
‪‪−40.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−160.00 K‬‬
‪‪−120.00 K‬‬
‪‪−80.00 K‬‬
‪‪−40.00 K‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
‪0.00‬
‪‪4.50 M‬‬
‪‪9.00 M‬‬
‪‪13.50 M‬‬
‪‪18.00 M‬‬
Actual
Estimate
Earnings
Next:Feb 25, 2026
‪−0.03‬
‪−0.02‬
‪−0.02‬
‪−0.01‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

VMED does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H1 '23
H2 '23
H1 '24
‪0.00‬
‪‪50.00 K‬‬
‪‪100.00 K‬‬
‪‪150.00 K‬‬
‪‪200.00 K‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪5.50 M‬‬
‪‪11.00 M‬‬
‪‪16.50 M‬‬
‪‪22.00 M‬‬
Assets
Liabilities